Updated: January 20, 2026
How to Help Your Patients Find Chlorthalidone/Clonidine in Stock: A Provider's Guide
Author
Peter Daggett

- The Immediate Priority: Preventing Clonidine Withdrawal
- Quick Reference: Clorpres Dose Equivalents
- Patient Counseling Points
- Is This an Opportunity to Reassess the Regimen?
- Using Real-Time Pharmacy Tools to Reduce Office Burden
- Insurance and Prior Authorization Considerations
- Follow-Up Monitoring Recommendations
Overview
Clorpres is discontinued. This provider's guide covers how to help patients transition to individual generics, avoid dangerous clonidine withdrawal, and find medications in stock.
Is Chlorthalidone/Clonidine in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Chlorthalidone/Clonidine near you.
When a patient calls your office asking why they can't fill their Clorpres prescription, the answer is simple: it's been permanently discontinued. But how you handle the transition that follows — quickly, safely, and with minimal friction for the patient — is where clinical judgment and practical systems make all the difference.
This guide is designed for prescribers, nurses, and care coordinators managing patients on Clorpres (clonidine hydrochloride/chlorthalidone). It covers the immediate steps to protect patients, how to bridge prescriptions quickly, how to evaluate whether this is an opportunity for regimen optimization, and how to use real-time pharmacy tools to reduce the administrative burden on your office.
The Immediate Priority: Preventing Clonidine Withdrawal
Every patient currently on Clorpres is at risk for clonidine withdrawal if they run out of medication and don't have an alternative in place. This isn't a minor concern — clonidine carries a black box warning specifically about abrupt discontinuation: rapid blood pressure rebound, nervousness, agitation, elevated catecholamines, and risk of hypertensive emergency.
The immediate action item: contact every patient currently on Clorpres in your panel, or at minimum respond same-day to anyone who calls. Issue two new individual prescriptions — generic clonidine and generic chlorthalidone — before their current supply runs out.
Check live stock now.
Quick Reference: Clorpres Dose Equivalents
Use this table to identify the equivalent individual generic doses for each Clorpres strength:
Clorpres 0.1/15 mg → Clonidine 0.1 mg (same frequency) + Chlorthalidone 25 mg once daily*
Clorpres 0.2/15 mg → Clonidine 0.2 mg (same frequency) + Chlorthalidone 25 mg once daily*
Clorpres 0.3/15 mg → Clonidine 0.3 mg (same frequency) + Chlorthalidone 25 mg once daily*
*Note: Clorpres contained 15 mg chlorthalidone; standalone tablets are typically 25 mg or 50 mg. Clinically review each patient for the appropriate standalone chlorthalidone dose, particularly in elderly patients or those with renal impairment, where the dose increase from 15 mg to 25 mg may warrant monitoring for hypotension or electrolyte imbalance.
Patient Counseling Points
When speaking with patients about this transition, emphasize:
Clorpres is permanently discontinued — it is not coming back, so there's no point waiting or searching further for it.
The transition to individual generics is medically equivalent and should not affect blood pressure control.
Do not stop taking clonidine suddenly. If they can't fill one prescription, they must still take their clonidine until the prescription is sorted out.
Both generic clonidine and chlorthalidone are very inexpensive and widely available at most pharmacies.
Is This an Opportunity to Reassess the Regimen?
For stable patients who have been on Clorpres for years without recent reassessment, this transition may be a natural point to review whether their regimen reflects current guideline recommendations. The 2025 ACC/AHA guidelines list chlorthalidone (one of the two Clorpres components) as a preferred first-line diuretic — so continuing chlorthalidone makes clinical sense. However, clonidine is no longer a first-line hypertension agent, and some patients may benefit from transitioning the clonidine component to an ACE inhibitor, ARB, or calcium channel blocker over time.
That said, do not rush this reassessment if the patient is stable and adherent. An unplanned medication change carries its own risks. Start with the equivalent transition, then schedule a follow-up visit if you want to optimize the regimen further.
Using Real-Time Pharmacy Tools to Reduce Office Burden
In most cases, generic clonidine and chlorthalidone will be immediately available at your patient's preferred pharmacy. But if a patient calls back saying their pharmacy is out of one or both, medfinder for Providers can help. The service contacts pharmacies near the patient to identify which ones have the prescription in stock — reducing back-and-forth with your office and getting patients their medications faster.
Insurance and Prior Authorization Considerations
Both generic clonidine and generic chlorthalidone are typically Tier 1 on most insurance formularies — meaning low or zero copay, no prior authorization required. The transition from Clorpres to the individual generics should not create insurance barriers for most patients. However, if a patient is on a plan that required prior authorization for Clorpres or has specific formulary restrictions, verify coverage in advance to prevent prescription delays.
Found
Rate
on average
Follow-Up Monitoring Recommendations
Blood pressure check within 4–6 weeks of transition to confirm stability
Electrolyte panel (especially potassium and sodium) if the chlorthalidone dose changed
Renal function (BMP or CMP) if the patient has preexisting kidney disease
Blood glucose check if the patient has diabetes — both clonidine and chlorthalidone can affect glycemic control
Frequently Asked Questions
Prescribe generic clonidine and generic chlorthalidone as separate prescriptions at the equivalent doses. For Clorpres 0.1/15 mg, prescribe clonidine 0.1 mg at the same frequency plus chlorthalidone 25 mg once daily. Act promptly — the clonidine component must not be allowed to lapse due to rebound hypertension risk.
Yes. If the patient is at risk of running out before you can complete the full transition plan, prescribing a short supply of generic clonidine immediately prevents the dangerous gap. The chlorthalidone transition, which carries less acute risk of discontinuation, can follow shortly after.
Yes, in most cases. Both generic clonidine and generic chlorthalidone are Tier 1 medications on most insurance formularies, typically with low or zero copays and no prior authorization requirements. The cost of both generics together is likely similar to or less than what the patient paid for Clorpres.
Referral is generally not necessary for a straightforward Clorpres-to-individual-generics transition. However, if the transition is being used as an opportunity to reassess the overall antihypertensive regimen in a complex patient (resistant hypertension, multiple comorbidities, significant cardiovascular disease), a cardiology or nephrology consult may be appropriate.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Chlorthalidone/Clonidine also looked for:
More about Chlorthalidone/Clonidine
38,781 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





